Details for Patent: 8,852,632
✉ Email this page to a colleague
Which drugs does patent 8,852,632 protect, and when does it expire?
Patent 8,852,632 protects ISENTRESS and is included in one NDA.
This patent has nineteen patent family members in fifteen countries.
Summary for Patent: 8,852,632
Title: | Pharmaceutical formulation containing a release rate controlling composition |
Abstract: | Pharmaceutical formulations suitable for oral administration in solid dosage forms are described. The compositions comprise an effective amount of a base salt of a compound of Formula (I) and a release rate controlling composition comprising a solubilizing agent, a gelling agent, and a water soluble filler; wherein R, R, Rand Rare defined herein. The formulations are suitable for use in the inhibition of HIV integrase, the treatment and prophylaxis of HIV infection, and the treatment, prophylaxis and delay in the onset of AIDS. |
Inventor(s): | Pourkavoos Nazaneen, Ney James R., Cruanes Maria T., Wu Yunhui, Palkar Saurabh A. |
Assignee: | Merck Sharp & Dohme Corp. |
Application Number: | US11792118 |
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 8,852,632
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Msd Sub Merck | ISENTRESS | raltegravir potassium | TABLET;ORAL | 022145-001 | Oct 12, 2007 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | TREATMENT OF HIV INFECTION | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,852,632
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2005311652 | ⤷ Try a Trial | |||
Brazil | PI0518781 | ⤷ Try a Trial | |||
Canada | 2588445 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |